HSBC analyst Damayanti Kerai upgraded Divi\'s Laboratories Ltd (DIVI:IN) from Reduce to Buy with a price target of INR7,900.00 (from ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE